https://www.indianpharmapost.com/jb-pharma-q1-fy26-pat-up-at-14-to-rs-202-cr-175222025-08-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharmaceutical-q1-fy26-consolidated-pat-falls-by-20-to-rs-2278-cr-175232025-08-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/iberia-pharmaceuticals-to-open-rs-70-crore-manufacturing-unit-in-india-175242025-08-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/lillys-mounjaro-shows-heart-health-benefits-in-head-to-head-trial-with-trulicity-175252025-08-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/uspto-issues-final-rejection-of-rampart-ics-radiation-shield-patent-claims-175262025-08-02T00:00:00+05:30always0.9https://www.indianpharmapost.com/agilent-and-tifr-hyderabad-join-hands-to-boost-metabolism-and-health-research-175272025-08-02T00:00:00+05:30always0.9